IL6 and lung carcinoma: However, the role of the β-catenin signaling mediated by PAK1 in lung cancer cell stemness is not fully understood, although the PAK1-mediated stem-like phenotype confers sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma9.